Top

Published in:

01-08-2006 | REVIEW

The neurological disorder associated with thyroid autoimmunity

Authors: Franco Ferracci, M.D, Antonio Carnevale, MD

Published in: Journal of Neurology | Issue 8/2006

Abstract

The neurological disorder associated with thyroid autoimmunity is an elusive disease that neurologists have learned to recognize in the last few years. The diagnosis is made, after excluding more common diseases, when neuropsychiatric symptoms develop in a patient with high serum concentrations of anti-thyroid antibodies. The clinical presentations of the disease and the many controversial issues surrounding the diagnosis, the pathogenesis, the role of thyroid autoantibodies, and the choice of therapy are reviewed and discussed in the light of the medical literature in English.

Arain A, Abou-Khalil B, Moses H (2001) Hashimoto’s encephalopathy: documentation of mesial temporal seizure by ictal EEG. Seizure 10:438–441PubMed

Avila A, Serrado A, Reig L, Famades A, Maho P (2003) Early presentation of gait disturbance in a steroid-responsive encephalopathy associated with autoimmune thyroiditis. Eur J Neurol 10:601PubMedCrossRef

Azuma T, Uemichi T, Funauchi M, Doi S, Matsubara T (2000) Myelopathy associated with Hashimoto’s disease. J Neurol Neurosurg Psychiatry 68:681–682PubMedCrossRef

Balestri P, Grosso S, Garibaldi G (1999) Alternating hemiplegia of childhood or Hashimoto’s encephalopathy?. J Neurol Neurosurg Psychiatry 66:548–549PubMed

Barker R, Zajicek J, Wilkinson I (1996) Thyrotoxic Hashimoto’s encephalopathy. J Neurol Neurosurg Psychiatry 60:234PubMed

Berio A, Piazzi A (2002) A case of Kearns-Sayre syndrome with autoimmune thyroiditis and possible Hashimoto encephalopathy. Panminerva Med 44:265–269PubMed

Bertoni M, Falcini M, Sestini S, et al. (2003) Encephalopathy associated with Hashimoto’s thyroiditis: an additional case. Eur J Intern Med 14:434–437PubMedCrossRef

Boers PM, Colebatch JG (2001) Hashimoto’s encephalopathy responding to plasmapheresis. J Neurol Neurosurg Psichiatry 70:132CrossRef

Bohnen NILJ, Parnell KJ, Harper CM (1997) Reversible MRI findings in a patient with Hashimoto’s encephalopathy. Neurology 49:246–247PubMed

10.

Bostantjopoulou S, Zafiriou D, Katsarou Z, Kazis A (1996) Hashimoto’s encephalopathy: clinical and laboratory findings. Funct Neurol 11:247–251PubMed

11.

Brain, Lord, Jellinek EH, Ball K (1966) Hashimoto’s disease and encephalopathy. Lancet 2:512–514PubMedCrossRef

12.

Byrne OC, Zuberi SM, Madigan CA, King MD (2000). Hashimoto’s thyroiditis-a rare but treatable cause of encephalopathy in children. Eur J Paediatr Neurol 4:279–282PubMedCrossRef

13.

Cantón A, de Fàbregas O, Tintoré M, et al. (2000) Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition?. J Neurol Sci. 176:65–69PubMedCrossRef

14.

Cao NJ, Tselis AC, Li J, Gorman M (2005) A case of Hashimoto’s encephalopathy: association with sensory ganglionopathy. J Neurol Sci 238:105–107PubMedCrossRef

15.

Castillo PR, Mignot E, Woodruff BK, Boeve BF (2004) Undetectable CSF hypocretin-1 in “Hashimoto’s encephalopathy” associated with coma. Neurology 62:1909PubMed

16.

Chaudhuri A, Behan PO (2003) The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto’s encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 10:1945–1953PubMedCrossRef

17.

Chen HC, Masharani U (2000) Hashimoto’s encephalopathy. South Med J 93:504–506PubMed

18.

Chen PL, Wang PY, Hsu HY (2005). Reversible electroencephalographic and single emission computed tomography abnormalities in Hashimoto’s encephalopathy. J Chin Med Assoc 68:77–81PubMedCrossRef

19.

Chong JY, Rowland LP, Utiger RD (2003) Hashimoto encephalopathy: syndrome or myth?. Arch Neurol 60:164–171PubMedCrossRef

20.

Cossu G, Melis M, Molari A, et al. (2003) Creutzfeld-Jakob disease associated with high titer of antithyroid antibodies. Case report and literature review. Neurol Sci 24:138–140PubMedCrossRef

21.

Creutzfeldt CJ, Haberl Rl (2005) Hashimoto encephalopathy: a do-not-miss in the differential diagnosis of dementia. J Neurol 1–3

22.

De Vries PJ, Hunt N, Crawford A, Hodges JR, Balan K (2000) Hashimoto’s encephalopathy presenting as “myxoedematous madness”. J Neurol Neurosurg Psychiatry 68:100–126CrossRef

23.

Desai J, Wadia N (1999) Hashimoto’s encephalopathy. J Neurol Sci 163: 202–203PubMedCrossRef

24.

Deutsch M, Koskinas J, Tzannos K, et al (2005) Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin. Ann Pharmacother 39:1745–1748PubMedCrossRef

25.

Doherty CP, Schlossmacher M, Torres N, et al. (2002) Hashimoto’s encephalopathy mimicking Creutzfeld-Jakob disease: brain biopsy findings. J Neurol Neurosurg Psychiatry 73: 601–602PubMedCrossRef

26.

Duffey P, Yee S, Reid IN, Bridges LR (2003) Hashimoto’s encephalopathy. Postmortem findings after fatal status epilepticus. Neurology 61:1124–1126PubMed

27.

Erickson JC, Carrasco H, Grimes JB, Jabbari B, Cannard KR (2002) Palatal tremor and myorhythmia in Hashimoto’s encephalopathy. Neurology 58:504–505PubMed

28.

Fatemi S, Bedri J, Nicoloff JT (2003) Encephalopathy associated with Hashimoto’s thyroiditis: use of serum immunoglobulin G as a marker of disease activity. Thyroid 13:227–228PubMedCrossRef

29.

Ferracci F, Bertiato G, Moretto G (2004) Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 217:165–168PubMedCrossRef

30.

Ferracci F, Moretto G, Candeago RM, et al. (2003) Anti-thyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto’s encephalopathy. Neurology 60:712–714PubMed

31.

Forchetti C, Katsamakis G, Garron DC (1997). Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology 49:623–626PubMed

32.

Fujii A, Yoneda M, Ito T, et al. (2005) Autoantibodies against the aminoterminal of alpha-enolase are a useful diagnostic marker of Hashimoto’s encephalopathy. J Neuroimmunol 162:130–136PubMedCrossRef

33.

Galluzzi S, Geroldi C, Zanetti O, Frisoni GB (2002) Hashimoto’s encephalopathy in the elderly: relationship to cognitive impairment. J Geriatr Psychiatr Neurol 15:175–179

34.

Ghika-Schmid F, Ghika J, Regli N, et al. (1996) Hashimoto’s myoclonic encephalopathy: an underdiagnosed treatable condition?. Mov Disord 11:555–562PubMedCrossRef

35.

Gukuyener K, Serdaroglu A, Bideci A, et al. (2000) Tremor and myoclonus heralding hashimoto’s encephalopathy. J Pediatr End Metab 13:1137–1141

36.

Henchey R, Cibula J, Helveston W, Malone J, Gilmore RL (1995) Electroencephalographic findings in Hashimoto’s encephalopathy. Neurology 45:977–981PubMed

37.

Hernàndez Echebarrìa LE, Saiz A, Graus F, et al. (2000) Detection of 14–3-3 protein in the CSF of a patients with Hashimoto’s encephalopathy. Neurology 54: 1539–1540PubMed

38.

Hussain NS, Rumbaugh J, Kerr D, Nath A, Hillis AE (2005) Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 64: 165–166PubMedCrossRef

39.

Ishii K, Hayashi A, Tamaoka A, et al. (1995) Case report: thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto’s encephalopathy. Am J Med Sci 310:202–205PubMed

40.

Isik U, Tennison M, D’Cruz O (2001) Recurrent encephalopathy and seizures in an adolescent girl. Clin Pediatr 40:273–275

41.

Jacob S, Rajabally YA (2005) Hashimoto’s encephalopathy: steroid resistance and response to intravenous immunoglobulins. J Neurol Neurosurg Psychiatry 76:455–456PubMedCrossRef

42.

Janes SE, Santosh B, Thomas D, Vyas H (2004) Hashimoto’s encephalopathy: an unusuale cause of seizures in the intensive care unit. Pediatr Crit Care Med 5:578–581PubMedCrossRef

43.

Kalita J, Misra UK, Rathore C, et al. (2003) Hashimoto’s encephalopathy: clinical, SPECT and neurophysiological data. QJM 96:455–457PubMedCrossRef

44.

Kastrup O, Maschke M, Schlamann K, Diener HC (2005) Hashimoto encephalopathy and neuralgic amyotrophy – causal link or chance association?. Eur Neurol 53:98–99PubMedCrossRef

45.

Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW (1996) Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 243:585–593PubMedCrossRef

46.

Mahad DJ, Staugaitis S, Ruggieri P, et al. (2005) Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci 228: 3–5PubMedCrossRef

47.

Mahmud FH, Ranaud DL, Reed AM, Brands CK (2003) Steroid-responsive encephalopathy associated with Hashimoto’s thyroiditis in an adolescent with chronic hallucinations and depression: case report and review. Pediatrics 112:686–690PubMedCrossRef

48.

Mancardi MM, Fazzini F, Rossi A, Gaggero R (2005) Hashimoto’s encephalopathy with selective involvement of the nucleus accumbens: a case report. Neuropediatrics 36:218–220PubMedCrossRef

49.

Maydell Bv, Kopp M, Komorowski GV, et al. (2002) Hashimoto encephalopathy-is it underdiagnosed in pediatric patients?. Neuropediatrics 33:86–89CrossRef

50.

McCabe DJ, Burke T, Connolly S, Hutchinson M (2000) Amnesic syndrome with bilateral mesial temporal lobe involvement in Hashimoto’s encephalopathy. Neurology 54:737–739PubMed

51.

McGinley J, McCabe DJ, Fraser A, et al. (2000) Hashimoto’s encephalopathy: an unusual cause of status epilepticus. Ir Med J 93:118PubMed

52.

McKeon A, McNamara B, Sweeney B (2004) Hashimoto’s encephalopathy presenting with psychosis and generalized absence status. J Neurol 251:1025–1027PubMedCrossRef

53.

Mignot E, Lammers GJ, Ripley B, et al. (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59:1553–1562PubMedCrossRef

54.

Müssig K, Bartels M, Galwitz B, et al. (2005) Hashimoto’s encephalopathy presenting with bipolar affective disorder. Bipolar Disord 7:1–6

55.

Nagpal T, Pande S (2004) Hashimoto’s encephalopathy: response to plasma exchange. Neurol India 52:245–247PubMed

56.

Nemeroff CB, Simon JS, Haggerty JJ, Evans DL (1985) Antithyroid antibodies in depressed patients. Am J Psychiatry 142:840–843PubMed

57.

Nieuwenhuis L, Santens P, Vanwalleghem P, Boon P (2004) Subacute Hashimoto’s encephalopathy treated with plasmapheresis. Acta Neurol Belg 104:80–83PubMed

58.

Nolte KW, Unbehaun A, Sieker H, Kloss TM, Paulus W (2000) Hashimoto encephalopathy: a brainstem vasculitis?. Neurology 54:769–770PubMed

59.

Ochi H, Horiuchi I, Araki N, et al. (2002) Proteonomic analysis of human brain identifies (-enolase as a novel autoantigen in Hashimoto’s encephalopathy. FEBS 528:197–202CrossRef

60.

Oide T, Tokuda T, Masahide Y, et al. (2004) Anti-neuronal antibody in Hashimoto’s encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients. J Neurol Sci 217: 7–12PubMedCrossRef

61.

Papathanasopoulos P, Mallioris K, Karanasios P, Dimopoulos D, Papapetropoulos T (2000) Febrile Hashimoto’s encephalopathy. J Neurol Neurosurg Psychiatry 68:795PubMedCrossRef

62.

Passarella B, Negro C, Nozzoli C., et al. (2005) Cerebellar subacute sindrome due to corticosteroid-responsive encephalopathy associated with autoimmune thyroiditis (also called “Hashimoto’s encephalopathy”). Clin Ter 156:13–17PubMed

63.

Peschen-Rosin R, Schabet M, Dichgans J (1999) Manifestation of Hashimoto’s encephalopathy years before onset of thyroid disease. Eur Neurol 41:79–84PubMedCrossRef

64.

Piga M, Serra A, Deiana L, et al. (2004). Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. Eur J Nucl Med Mol Im 31:1639–1644CrossRef

65.

Pozo-Rosich P, Villoslada P, Canton A, et al. (2002) Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease. J Neurol 249:1063–1065PubMedCrossRef

66.

Rekand T, Vedeler C, Gramstad A, Bindoff L (2003) Hashimoto’s encephalopathy: a treatable cause of mental impairment, stroke and seizures. Eur J Neurol 10:746–747PubMedCrossRef

67.

Schäuble B, Castillo PR, Boeve BF, Westmoreland BF (2003) EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 114:32–37PubMedCrossRef

68.

Seipelt M, Zerr I, Nau R, et al. (1999) Hashimoto’s encephalitis as a differential diagnosis of Creutzfeld-Jakob disease. J Neurol Neurosurg Psychiatry 66:172–176PubMedCrossRef

69.

Sellal F, Berton C, Andriantseheno M, Clerc C (2002) Hashimoto’s encephalopathy. Exacerbations associated with menstrual cycle. Neurology 59:1633–1635PubMed

70.

Seo SW, Lee BI, Lee JD, et al. (2003) Thyrotoxic autoimmune encephalopathy: a repeat positron emission tomography study. J Neurol Neurosurg Psychiatry 74:504–506PubMedCrossRef

71.

Shaw PJ, Bates D, Kendall-Taylor P (1988) Hyperthyroidism presenting as pyramidal tract disease. BMJ 297:1395–1396PubMedCrossRef

72.

Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE (1991) Hashimoto’s encephalopathy: a steroid responsive disorder associated with high anti-thyroid antibody titers-report of 5 cases. Neurology 41:228–233PubMed

73.

Shein M, Apter A, Dickerman Z, Tyano S, Gadoth N (1986) Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain Dev 8:60–64PubMed

74.

Sheng B, Lau KK, Li HL, Cheng LF (2005) A case of Hashimoto’s encephalopathy with demyelinating peripheral neuropathy. Eur Neurol 53:84–85PubMedCrossRef

75.

Skodda S, Kraus M, Durwen H, Gehlen W (1999) Hashimoto’s encephalopathy associated with isolated ACTH deficiency and hyponatremia: a case report. J Neurol 246:970–971PubMedCrossRef

76.

Sommerfield AJ, Stimson R, Campbell IW (2004) Hashimoto’s encephalopathy presenting as an acute medical emergency. Scott Med J 49:155–156PubMed

77.

Song YM, Seo DW, Chang GY (2004) MR findings in Hashimoto encephalopathy. Am J Neuroradiol 25:807–808PubMed

78.

Spiegel J, Hellwig D, Becker G, Műller M (2004) Progressive dementia caused by Hashimoto’s encephalopathy-report of two cases. Eur J Neurol 11:711–713PubMedCrossRef

79.

Sue CM, Morris JGL (1997). Another case of Hashimoto’s encephalopathy. Mov Disord 12:471–472PubMed

80.

Suzuki N, Mitamura R, Ohmi H, et al. (1994) Hashimoto thyroiditis, distal renal tubular acidosis, pernicious anemia and encephalopathy: a rare combination of auto-immune disorders in a 12-year-old girl. Eur J Pediatr 153:78–79PubMed

81.

Sybesma CA, Pinxteren-Nagler EV, Sinnige LGF, van Oostrom JCH, de Vries TW (1999). Hashimoto encephalopathy in a 12-year-old girl Eur J Pediatr 158: 867PubMedCrossRef

82.

Takahashi S, Mitamura R, Itoh Y, Suzuki N, Okuno A (1994) Hashimoto encephalopathy: etiologic considerations. Pediatr Neurol 11:328–331PubMedCrossRef

83.

Taurin G. Golfier V, Pinel JF, et al. (2002) Choreic syndrome due to Hashimoto’s encephalopathy. Mov Disord 17:1091–1092CrossRef

84.

Taylor SE, Garalda ME, Tudor-Williams G, Martinez-Alier N (2003) An organic cause of neuropsychiatric illness in adolescence. Lancet 361:572PubMedCrossRef

85.

Thrush DC, Boddie HG (1974) Episodic encephalopathy associated with thyroid disorders. J Neurol Neurosurg Psychiatry 37:696–700PubMedCrossRef

86.

Tumani H, Nölker G, Reiber H (1995) Relevance of cerebrospinal fluid parameters for early diagnosis in neuroborreliosis. Neurology 45:1663–1670PubMed

87.

Vander T, Hallevy C, Alsaed I, et al. (2004) 14–3-3 protein in the CSF of a patient with Hashimoto’s encephalopathy. J Neurol 251:1273–1274PubMedCrossRef

88.

Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM (1999) Pediatric manifestations of Hashimoto’s encephalopathy. Pediatr Neurol 20:394–398PubMedCrossRef

89.

Warren CL, Sawhney IMS (2004) Encephalopathy with hypothyroidism. J R Soc Med 97:287–288PubMedCrossRef

90.

Watemberg N, Willis D, Pellock JM (2000). Encephalopathy as the presenting symptom of Hashimoto’s thyroiditis. J Child Neurol 15:66–69PubMed

91.

Zettinig G, Asenbaum S, Fueger BJ, et al. (2003) Increased prevalence of subclinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto’s encephalopathy?. Clin Endocrinol 59:637–643CrossRef

Title: The neurological disorder associated with thyroid autoimmunity
Authors: Franco Ferracci, M.D
Antonio Carnevale, MD
Publication date: 01-08-2006
Publisher: Steinkopff-Verlag
Published in: Journal of Neurology / Issue 8/2006
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-006-0170-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The neurological disorder associated with thyroid autoimmunity

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2006

Recovery from mild traumatic brain injury

Blink amplitude but not saccadic hypometria indicates carriers of Parkin mutations

Comparison of a simple method for quantitation of intraepidermal nerve fibres with a standard image analysis method using hypothenar skin

Benign multiple sclerosis

Mutation of the highly conserved cysteine residue 131 of the SCA14 associated PRKCG gene in a family with slow progressive cerebellar ataxia

CSF prostaglandin D synthase is reduced in excessive daytime sleepiness